{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:48:31Z","timestamp":1790516911206,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T00:00:00Z","timestamp":1386288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11046-013-9719-z","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T02:44:51Z","timestamp":1386211491000},"page":"11-18","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy of the Combination of Voriconazole and Caspofungin in Experimental Pulmonary Aspergillosis by Different Aspergillus Species"],"prefix":"10.1007","volume":"177","author":[{"given":"Ming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Kui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,6]]},"reference":[{"key":"9719_CR1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2217\/fmb.11.4","volume":"6","author":"E Snelders","year":"2011","unstructured":"Snelders E, Melchers WJ, Verweij PE. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis? Future Microbiol. 2011;6:335\u201347.","journal-title":"Future Microbiol"},{"key":"9719_CR2","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1086\/323900","volume":"33","author":"J Perfect","year":"2001","unstructured":"Perfect J, Cox G, Lee J, Kauffman C, De Repentigny L, Chapman S, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33:1824\u201333.","journal-title":"Clin Infect Dis"},{"key":"9719_CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/13693780701885552","volume":"46","author":"KA Marr","year":"2008","unstructured":"Marr KA. Fungal infections in hematopoietic stem cell transplant recipients. Med Mycol. 2008;46:293\u2013302.","journal-title":"Med Mycol"},{"key":"9719_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327\u201360.","journal-title":"Clin Infect Dis"},{"key":"9719_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/qjmed\/hcm035","volume":"100","author":"O Zmeili","year":"2007","unstructured":"Zmeili O, Soubani A. Pulmonary aspergillosis: a clinical update. QJM. 2007;100:317\u201334.","journal-title":"QJM"},{"key":"9719_CR6","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2146\/ajhp060584","volume":"64","author":"RE Greene","year":"2007","unstructured":"Greene RE, Mauskopf J, Roberts CS, Zyczynski T, Schlamm HT. Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis. Am J Health-Syst Pharm. 2007;64:2561\u20138.","journal-title":"Am J Health-Syst Pharm"},{"key":"9719_CR7","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1086\/375420","volume":"187","author":"V Petraitis","year":"2003","unstructured":"Petraitis V, Petraitiene R, Sarafandi AA, Kelaher AM, Lyman CA, Casler HE, et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis. 2003;187:1834\u201343.","journal-title":"J Infect Dis"},{"key":"9719_CR8","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/AAC.47.4.1452-1455.2003","volume":"47","author":"JC Luque","year":"2003","unstructured":"Luque JC, Clemons KV, Stevens DA. Efficacy of micafungin alone or in combination against systemic murine aspergillosis. Antimicrob Agents Chemother. 2003;47:1452\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"9719_CR9","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.46.8.2564-2568.2002","volume":"46","author":"WR Kirkpatrick","year":"2002","unstructured":"Kirkpatrick WR, Perea S, Coco BJ, Patterson TF. Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother. 2002;46:2564\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"9719_CR10","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/AAC.01556-08","volume":"53","author":"WW Sande van de","year":"2009","unstructured":"van de Sande WW, Mathot RA, Marian T, van Vianen W, Tavakol M, Rijnders BJ, et al. Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin. Antimicrob Agents Chemother. 2009;53:2005\u201313.","journal-title":"Antimicrob Agents Chemother"},{"key":"9719_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/13693780500148350","volume":"44","author":"KV Clemons","year":"2006","unstructured":"Clemons KV, Stevens DA. Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis. Med Mycol. 2006;44:69\u201373.","journal-title":"Med Mycol"},{"key":"9719_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000096348","volume":"78","author":"C Wagner","year":"2006","unstructured":"Wagner C, Graninger W, Presterl E, Joukhadar C. The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology. 2006;78:161\u201377.","journal-title":"Pharmacology"},{"key":"9719_CR13","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/AAC.00329-09","volume":"53","author":"V Petraitis","year":"2009","unstructured":"Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, et al. Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration-and dose-dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrob Agents Chemother. 2009;53:2382\u201391.","journal-title":"Antimicrob Agents Chemother"},{"key":"9719_CR14","first-page":"0868","volume":"27","author":"KA Marr","year":"2012","unstructured":"Marr KA, Schlamm H, Rottinghaus ST, Jagannatha S, Bow EJ, Wingard JR, et al. A randomised, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis. Mortality. 2012;27:0868.","journal-title":"Mortality"},{"key":"9719_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11046-011-9507-6","volume":"173","author":"E Calvo","year":"2012","unstructured":"Calvo E, Pastor FJ, Salas V, Mayayo E, Guarro J. Combined Therapy of Voriconazole and Anidulafungin in Murine Infections by Aspergillus flavus. Mycopathologia. 2012;173:251\u20137.","journal-title":"Mycopathologia"},{"key":"9719_CR16","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1128\/AAC.49.9.3697-3701.2005","volume":"49","author":"DM MacCallum","year":"2005","unstructured":"MacCallum DM, Whyte JA, Odds FC. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrob Agents Chemother. 2005;49:3697\u2013701.","journal-title":"Antimicrob Agents Chemother"},{"key":"9719_CR17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1469-0691.2009.02913.x","volume":"15","author":"W Hope","year":"2009","unstructured":"Hope W, Drusano G. Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside. Clin Microbiol Infect. 2009;15:602\u201312.","journal-title":"Clin Microbiol Infect"},{"key":"9719_CR18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijantimicag.2006.01.003","volume":"27","author":"D Lev\u00eaque","year":"2006","unstructured":"Lev\u00eaque D, Nivoix Y, Jehl F, Herbrecht R. Clinical pharmacokinetics of voriconazole. Int J Antimicrob Agents. 2006;27:274\u201384.","journal-title":"Int J Antimicrob Agents"},{"key":"9719_CR19","unstructured":"Rex JH. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved Standard: Clinical and Laboratory Standards Institute; 2008."},{"key":"9719_CR20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/AAC.48.3.970-978.2004","volume":"48","author":"E Dannaoui","year":"2004","unstructured":"Dannaoui E, Lortholary O, Dromer F. In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother. 2004;48:970\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"9719_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2012.02.003","volume":"73","author":"S Krishnan-Natesan","year":"2012","unstructured":"Krishnan-Natesan S, Wenjuan W, Chandrasekar PH. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2012;73:135\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"9719_CR22","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/AAC.49.3.1232-1235.2005","volume":"49","author":"M Cuenca-Estrella","year":"2005","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G, Alcazar-Fuoli L, Mellado E, Buitrago MJ, et al. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus. Antimicrob Agents Chemother. 2005;49:1232\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"9719_CR23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jac\/dks402","volume":"68","author":"S Seyedmousavi","year":"2013","unstructured":"Seyedmousavi S, Br\u00fcggemann RJ, Melchers WJ, Rijs AJ, Verweij PE, Mouton JW. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis. J Antimicrob Chemother. 2013;68:385\u201393.","journal-title":"J Antimicrob Chemother"},{"key":"9719_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2012.02.003","volume":"73","author":"S Krishnan-Natesan","year":"2012","unstructured":"Krishnan-Natesan S, Wu W, Chandrasekar PH. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp 51A mutants of Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2012;73:135\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"9719_CR25","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1128\/JCM.02214-09","volume":"48","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Park S, Warn P, Shrief R, Harrison E, Perlin DS. Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification. J Clin Microbiol. 2010;48:1378\u201383.","journal-title":"J Clin Microbiol"},{"key":"9719_CR26","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1128\/AAC.00674-10","volume":"54","author":"PL Giudice","year":"2010","unstructured":"Giudice PL, Campo S, Verdoliva A, Rivieccio V, Borsini F, De Santis R, et al. Efficacy of PTX3 in a rat model of invasive aspergillosis. Antimicrob Agents Chemother. 2010;54:4513\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"9719_CR27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.tp.0000202421.94822.f7","volume":"81","author":"N Singh","year":"2006","unstructured":"Singh N, Limaye AP, Forrest G, Safdar N, Munoz P, Pursell K, et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation. 2006;81:320\u20136.","journal-title":"Transplantation"},{"key":"9719_CR28","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1099\/jmm.0.018309-0","volume":"59","author":"AK Person","year":"2010","unstructured":"Person AK, Chudgar SM, Norton BL, Tong BC, Stout JE. Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis. J Med Microbiol. 2010;59:834\u20138.","journal-title":"J Med Microbiol"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-013-9719-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-013-9719-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-013-9719-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T12:43:45Z","timestamp":1564922625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-013-9719-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,6]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9719"],"URL":"https:\/\/doi.org\/10.1007\/s11046-013-9719-z","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,6]]}}}